Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension.

J. Oto (Valencia, Spain), O. Tura-Ceide (Barcelona, Spain), V. Sánchez-López (Sevilla, Spain), J. Osorio (Barcelona, Spain), C. Bonjoch (Barcelona, Spain), D. Hervás (Valencia, Spain), E. Arellano (Sevilla, Spain), P. Medina (Valencia, Spain), I. Blanco (Barcelona, Spain), V. Peinado (Barcelona, Spain), R. Otero (Sevilla, Spain), J. Barberà (Barcelona, Spain)

Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Session: Pulmonary hypertension: novelties from the bench
Session type: Poster Discussion
Number: 5050
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Oto (Valencia, Spain), O. Tura-Ceide (Barcelona, Spain), V. Sánchez-López (Sevilla, Spain), J. Osorio (Barcelona, Spain), C. Bonjoch (Barcelona, Spain), D. Hervás (Valencia, Spain), E. Arellano (Sevilla, Spain), P. Medina (Valencia, Spain), I. Blanco (Barcelona, Spain), V. Peinado (Barcelona, Spain), R. Otero (Sevilla, Spain), J. Barberà (Barcelona, Spain). Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension.. 5050

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RNA expression pattern of peripheral blood B-lymphocytes in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007


Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007


Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2006 - Cellular mechanisms of airway disease
Year: 2006


Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006

Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009

Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002

Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension},
Source: Eur Respir J 2012; 40: 895-904
Year: 2012



P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010


Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
Source: Eur Respir J 2008; 31: 135-139
Year: 2008



Shroom expression is attenuated in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 871-880
Year: 2008



Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009